Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report
PT Nelson, DW Dickson, JQ Trojanowski, CR Jack… - Brain, 2019 - academic.oup.com
We describe a recently recognized disease entity, limbic-predominant age-related TDP-43
encephalopathy (LATE). LATE neuropathological change (LATE-NC) is defined by a …
encephalopathy (LATE). LATE neuropathological change (LATE-NC) is defined by a …
[PDF][PDF] Immune signaling in neurodegeneration
TR Hammond, SE Marsh, B Stevens - Immunity, 2019 - cell.com
Neurodegenerative diseases of the central nervous system progressively rob patients of
their memory, motor function, and ability to perform daily tasks. Advances in genetics and …
their memory, motor function, and ability to perform daily tasks. Advances in genetics and …
Lysosome trafficking and signaling in health and neurodegenerative diseases
PPY Lie, RA Nixon - Neurobiology of disease, 2019 - Elsevier
Lysosomes, single-membrane organelles defined by a uniquely strong acidic lumenal pH
and high content of acid hydrolases, are the shared degradative compartments of the …
and high content of acid hydrolases, are the shared degradative compartments of the …
neuropathology of non‐tau frontotemporal lobar degeneration
M Neumann, IRA Mackenzie - Neuropathology and applied …, 2019 - Wiley Online Library
Frontotemporal dementia (FTD) is a heterogeneous clinical syndrome associated with
frontotemporal lobar degeneration (FTLD) as a relatively consistent neuropathological …
frontotemporal lobar degeneration (FTLD) as a relatively consistent neuropathological …
[HTML][HTML] Proteomics approaches for biomarker and drug target discovery in ALS and FTD
Neurodegenerative disorders such as amyotrophic lateral sclerosis (ALS) and
frontotemporal dementia (FTD) are increasing in prevalence but lack targeted therapeutics …
frontotemporal dementia (FTD) are increasing in prevalence but lack targeted therapeutics …
Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for …
Frontotemporal lobar degeneration with neuronal inclusions of the TAR DNA-binding protein
43 (FTLD-TDP) represents the most common pathological subtype of FTLD. We established …
43 (FTLD-TDP) represents the most common pathological subtype of FTLD. We established …
Pathological, imaging and genetic characteristics support the existence of distinct TDP-43 types in non-FTLD brains
KA Josephs, ME Murray, N Tosakulwong… - Acta …, 2019 - Springer
TDP-43 is present in a high proportion of aged brains that do not meet criteria for
frontotemporal lobar degeneration (FTLD). We determined whether there are distinct TDP …
frontotemporal lobar degeneration (FTLD). We determined whether there are distinct TDP …
[HTML][HTML] Tau and TDP-43 proteinopathies: kindred pathologic cascades and genetic pleiotropy
We review the literature on Tau and TDP-43 proteinopathies in aged human brains and the
relevant underlying pathogenetic cascades. Complex interacting pathways are implicated in …
relevant underlying pathogenetic cascades. Complex interacting pathways are implicated in …
Genetics and molecular mechanisms of frontotemporal lobar degeneration: an update and future avenues
R Ferrari, C Manzoni, J Hardy - Neurobiology of aging, 2019 - Elsevier
Frontotemporal lobar degeneration (FTLD) is the second most common form of dementia
after Alzheimer's disease. The study and the dissection of FTLD is complex due to its clinical …
after Alzheimer's disease. The study and the dissection of FTLD is complex due to its clinical …
TMEM106B Effect on cognition in Parkinson disease and frontotemporal dementia
Objective Common variants near TMEM106B associate with risk of developing
frontotemporal dementia (FTD). Emerging evidence suggests a role for TMEM106B in …
frontotemporal dementia (FTD). Emerging evidence suggests a role for TMEM106B in …